SGP

(redirected from Schering-Plough)
Also found in: Wikipedia.
AcronymDefinition
SGPSingapore (ISO Country code)
SGPSpeedway Grand Prix
SGPStaatkundig Gereformeerde Partij
SGPStability and Growth Pact (aka Growth and Stability Pact)
SGPSchweizerische Gesellschaft für Pädiatrie (German: Swiss Society of Pediatrics)
SGPSchweizerische Gesellschaft Für Psychiatrie Und Psychotherapie
SGPSiemens Graduate Program (management training program)
SGPSimmering-Graz-Pauker AG (Austrian industrial conglomerates)
SGPSensory Graphplan
SGPSimplified General Perturbations
SGPStrain Gradient Plasticity
SGPSoukup Graphic Programming
SGPStreptomyces Griseus Protease
SGPScreenwriters Guild of the Philippines
SGPSmart Gradient-Project (algorithm)
SGPSustainable Green Printing Supplies
SGPScope Guidance Package
SGPSkills Gap Program
SGPSpirit of Grand Prairie, Inc. (Grand Prairie, TX)
SGPStudent Grant Program (various organizations)
SGPScottish Green Party
SGPSheep and Goat Pox
SGPSouthern Great Plains
SGPSchering-Plough (stock symbol)
SGPSafer Guildford Partnership (UK)
SGPSenior Politico-Military Group on Proliferation (NATO)
SGPSmall Grants Program (various organizations)
SGPSistemas Globales de Posicionamiento (Spanish)
SGPShell Gasification Process
SGPSlave Geological Province (Canada)
References in periodicals archive ?
Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs 29
Investors alleged in lawsuits that Schering-Plough deliberately misled them by not disclosing an FDA warning that the company was at "serious risk of a significant regulatory action.
To listen live to the Schering-Plough second quarter earnings conference call,
Schering-Plough selected Jones Lang LaSalle after a comprehensive and competitive selection process that included major corporate real estate services firms.
The planned acquisition of NeoGenesis will help strengthen the discovery capabilities of Schering-Plough, as we secure ownership of innovative drug discovery technology and intellectual property," said Fred Hassan, chairman and chief executive officer, Schering-Plough Corporation.
Pharmacopeia and Schering-Plough began their relationship in 1994, initially focusing their small molecule drug discovery activities on asthma and cancer, and later extending into other therapeutic areas.
Those wishing to listen live to the Webcast of the Special Meeting should go to the Investor Relations section of the Schering-Plough corporate Web site, http://www.
Schering-Plough markets ribavirin, USP capsules under the brand name REBETOL.
It is alleged that Schering-Plough issued a series of material misrepresentations in its filings with the Securities and Exchange Commission and press releases which artificially inflated the value of Schering-Plough shares.
The proposed settlement, as more fully described in a Form 8-K being filed today, provides for Schering-Plough to make additional disclosures related to the proposed merger, which are contained in the Form 8-K.
Schering-Plough will grant to Three Rivers a non-exclusive, non-sublicensable license to its United States ribavirin patents.